Bitget App
スマートな取引を実現
暗号資産を購入市場取引先物Bitget Earn広場もっと見る

JUBLPHARMA stock price forecast

How will JUBLPHARMA stock perform in 2026 and 2030?

This page primarily displays the projected price range for JUBLPHARMA stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of JUBLPHARMA, the development trends of Jubilant Pharmova Limited, and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for JUBLPHARMA. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Jubilant Pharmova Limited's financial performance and industry trends to provide short-term price predictions for JUBLPHARMA stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year JUBLPHARMA stock price forecast

Price target:
1898.48 INR
+107.94%
Based on 1-year price forecasts from 85 analysts, the highest estimate is 2877.58 INR, while the lowest estimate is 769.35 INR.

Analyst rating for JUBLPHARMA

Based on ratings from 45 analysts over the past three months, the overall consensus is Strong sell.

Strong buy
5
Buy
2
Hold
2
Sell
22
Strong sell
14

よくあるご質問

How has JUBLPHARMA's EPS performed recently?

JUBLPHARMA's EPS is projected to reach 6.900 INR next quarter. Explore more Jubilant Pharmova Limited financial data and stay up to date on the company's latest developments on the JUBLPHARMA stock details page.

What is the revenue forecast for JUBLPHARMA next quarter?

Jubilant Pharmova Limited's revenue is projected to reach 21.00B INR INR in the next quarter. You can view Jubilant Pharmova Limited's revenue and earnings on the JUBLPHARMA stock details page.

What is the price target for JUBLPHARMA?

Based on analyst estimates, the most likely target price for JUBLPHARMA over the next 12 months is 1898.48 INR, with a projected high of 2877.58 INR and a projected low of 769.35 INR. To track whether this target is reached within the next year, you can view the JUBLPHARMA stock price chart on the JUBLPHARMA stock details page to check the current JUBLPHARMA stock price, or follow the latest developments related to JUBLPHARMA on the JUBLPHARMA Stock News page.

What is the analyst rating for JUBLPHARMA?

We collected ratings from 45 analysts who have evaluated JUBLPHARMA stock over the past three months. Most analysts maintain a Strong sell outlook, and after aggregating all opinions, the overall consensus rating is Strong sell. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of JUBLPHARMA stock in 2030?

Based on price forecasts and analyses of Jubilant Pharmova Limited from Wall Street analysts and major investment banks, JUBLPHARMA is projected to trade between 1826.00 INR and 9130.00 INR in 2030.

JUBLPHARMAの株価変動

最終取引日において、JUBLPHARMA株式の終値は913.00 INRで、1日の価格変動は-3.21%でした。

株式先物を取引JUBLPHARMA stock details

Bitgetについて

世界初のユニバーサル取引所(UEX)では、ユーザーは暗号資産だけでなく、株式、ETF、外国為替、金、現実資産(RWA)も取引できます。
詳細を見る
NSE/
JUBLPHARMA stock price forecast
© 2026 Bitget